A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 107,400 shares of ALDX stock, worth $514,446. This represents 0.0% of its overall portfolio holdings.

Number of Shares
107,400
Previous 503,300 78.66%
Holding current value
$514,446
Previous $1.67 Million 65.29%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$3.19 - $6.32 $1.26 Million - $2.5 Million
-395,900 Reduced 78.66%
107,400 $578,000
Q2 2024

Aug 09, 2024

SELL
$3.25 - $4.72 $729,267 - $1.06 Million
-224,390 Reduced 30.84%
503,300 $1.67 Million
Q1 2024

May 13, 2024

BUY
$2.77 - $4.22 $1.18 Million - $1.8 Million
427,690 Added 142.56%
727,690 $2.38 Million
Q4 2023

Feb 13, 2024

BUY
$1.47 - $6.06 $114,954 - $473,891
78,200 Added 35.26%
300,000 $1.05 Million
Q3 2023

Nov 14, 2023

SELL
$6.11 - $8.16 $510,527 - $681,816
-83,556 Reduced 27.36%
221,800 $1.48 Million
Q2 2023

Aug 11, 2023

BUY
$7.11 - $11.89 $412,067 - $689,096
57,956 Added 23.43%
305,356 $2.56 Million
Q1 2023

May 12, 2023

BUY
$5.77 - $9.93 $195,603 - $336,627
33,900 Added 15.88%
247,400 $2.46 Million
Q4 2022

Feb 13, 2023

SELL
$5.08 - $7.09 $837,184 - $1.17 Million
-164,800 Reduced 43.56%
213,500 $1.49 Million
Q3 2022

Nov 14, 2022

SELL
$3.8 - $7.74 $516,040 - $1.05 Million
-135,800 Reduced 26.42%
378,300 $2.02 Million
Q2 2022

Aug 12, 2022

BUY
$2.43 - $4.85 $1.25 Million - $2.49 Million
514,100 New
514,100 $2.05 Million
Q1 2021

May 13, 2021

SELL
$6.53 - $14.42 $351,314 - $775,796
-53,800 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$6.31 - $8.13 $339,478 - $437,394
53,800 New
53,800 $369,000
Q3 2020

Nov 13, 2020

SELL
$4.0 - $7.53 $318,472 - $599,523
-79,618 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$1.97 - $5.05 $1.02 Million - $2.61 Million
-516,782 Reduced 86.65%
79,618 $332,000
Q1 2020

May 14, 2020

BUY
$1.62 - $6.4 $837,864 - $3.31 Million
517,200 Added 653.03%
596,400 $1.47 Million
Q4 2019

Feb 13, 2020

BUY
$4.73 - $7.98 $374,616 - $632,016
79,200 New
79,200 $460,000
Q3 2019

Nov 13, 2019

SELL
$4.41 - $6.12 $397,782 - $552,024
-90,200 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$6.0 - $9.0 $541,200 - $811,800
90,200 New
90,200 $541,000
Q1 2019

May 14, 2019

SELL
$7.14 - $9.85 $85,680 - $118,200
-12,000 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$7.26 - $13.29 $87,120 - $159,480
12,000 New
12,000 $100,000

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $279M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.